← Back to Search

COVID-19 Testing + Vaccine Education for Children with Developmental Disabilities

N/A

Waitlist Available

Research Sponsored by University of Rochester

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 16 months

Awards & highlights

Study Summary

This trial is conducted to see how effective different ways of preventing COVID-19 are in a school setting. It will help answer questions about how the virus spreads and if there are people who can spread the virus without showing symptoms. The trial will also look at vaccination rates and any hesitancy to get the vaccine.

Who is the study for?

This trial is for children aged 3-18 with intellectual and developmental disabilities (IDD) at the Mary Cariola Center, as well as staff aged 18-72. Participants must be able to undergo nasal swabs and blood tests safely. Staff planning to leave within a month or those with conditions that make swabbing or blood draws unsafe cannot join.Check my eligibility

What is being tested?

The study aims to prevent COVID-19 spread in schools by testing how activities affect infection rates, identifying asymptomatic cases, examining vaccination impact, and understanding vaccine hesitancy. It involves RT-PCR tests for detecting the virus and an educational campaign about COVID-19 vaccines.See study design

What are the potential side effects?

There are no direct side effects from participating in this trial since it involves diagnostic testing (nasal swabs) and education on vaccines rather than administering any drugs or vaccines.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 16 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~16 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 16 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Mean change in anxiety in staff

Mean change in anxiety in students

Mean change in depression in staff

+7 more

Trial Design

1Treatment groups

Experimental Treatment

Group I: Students and staff at Mary Cariola CenterExperimental Treatment2 Interventions

All students enrolled at the Mary Cariola Center in Rochester, NY. All staff working at the Mary Cariola Center in Rochester, NY.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of RochesterLead Sponsor

835 Previous Clinical Trials

517,376 Total Patients Enrolled

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)NIH

1,958 Previous Clinical Trials

2,672,565 Total Patients Enrolled

Media Library

COVID-19 RT-PCR test Clinical Trial Eligibility Overview. Trial Name: NCT04887129 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who meets the criteria to partake in this experiment?

"This investigation aims to include 950 individuals, aged 3 to 72, diagnosed with developmental impairments. The requirements for potential participants are as follows: 18 - 72 years old; expecting their current job will end within a month (e.g., retirement); students of the Mary Cariola Center; and finally those aged between 3-18."

Answered by AI

To what extent does this research involve patient participation?

"Affirmative. According to data hosted on clinicaltrials.gov, this medical trial is actively seeking participants since it was initially posted on May 3rd 2021 and most recently updated on June 13th 2022. A total of 950 individuals are being recruited from a single site."

Answered by AI

Are geriatric participants eligible for participation in this experiment?

"The study welcomes participants between the ages of 3 to 72. For those under 18, there are 162 studies available and 919 trials for elderly individuals over 65 years old."

Answered by AI

Are there still spaces available in this experiment?

"Affirmative. Clinicaltrials.gov confirms that this clinical research project, which was first uploaded on May 3rd 2021 is actively seeking participants. Approximately 950 patients need to be sourced from 1 medical facilities."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Testing for COVID-19 in High Risk Children With Intellectual and Developmental Disabilities (COV-IDD)

John Foxe 2021. "Testing for COVID-19 in High Risk Children With Intellectual and Developmental Disabilities (COV-IDD)". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04887129.